Jeong Tae Heum
Insider CIK 1317190 · RNN Chief Financial Officer · NRBO Director · CLNN Chief Finance Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CLNN Clene Inc. | A Award deriv | 2021-11-04 | 2021-11-04 | 62,500 | — | $0 | 62,500 | SEC↗ |
| CLNN Clene Inc. | A Award deriv | 2021-04-30 | 2021-04-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CLNN Clene Inc. | A Award deriv | 2021-02-01 | 2021-02-03 | 130,000 | $6.55 | $851.5K | 130,000 | SEC↗ |
| NRBO NeuroBo Pharmaceuticals, I | A Award deriv | 2020-01-13 | 2020-01-15 | 60,000 | — | $0 | 60,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2017-01-20 | 2017-01-24 | 300,000 | — | $0 | 300,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2017-01-20 | 2017-01-24 | 63,000 | — | $0 | 63,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2016-01-28 | 2016-02-01 | 98,853 | — | $0 | 98,853 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2016-01-28 | 2016-02-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2015-01-23 | 2015-01-27 | 333,332 | — | $0 | 333,332 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | M Exercise deriv | 2015-01-12 | 2015-01-12 | 49,800 | — | $0 | 182,728 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | M Exercise | 2015-01-12 | 2015-01-12 | 49,800 | $0.80 | $39.8K | 554,800 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | S Sale | 2015-01-12 | 2015-01-12 | 49,800 | $0.91 | $45.3K | 505,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | M Exercise deriv | 2015-01-09 | 2015-01-12 | 188,690 | — | $0 | 232,528 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | M Exercise | 2015-01-09 | 2015-01-12 | 188,690 | $0.80 | $151.0K | 693,690 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | S Sale | 2015-01-09 | 2015-01-12 | 188,690 | $0.92 | $173.6K | 505,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | M Exercise deriv | 2015-01-08 | 2015-01-12 | 78,782 | — | $0 | 421,218 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | S Sale | 2015-01-08 | 2015-01-12 | 78,782 | $0.90 | $70.9K | 505,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | M Exercise | 2015-01-08 | 2015-01-12 | 78,782 | $0.80 | $63.0K | 583,782 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2014-01-12 | 2014-01-14 | 175,000 | — | $0 | 175,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | M Exercise deriv | 2013-09-09 | 2013-09-11 | 150,000 | — | $0 | 0 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | S Sale | 2013-09-09 | 2013-09-11 | 71,139 | $0.46 | $32.7K | 505,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | F Tax w/h | 2013-09-09 | 2013-09-11 | 78,861 | $0.46 | $36.3K | 576,139 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | M Exercise | 2013-09-09 | 2013-09-11 | 150,000 | $0.24 | $36.0K | 655,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2013-03-01 | 2013-03-05 | 250,000 | — | $0 | 250,000 | SEC↗ |